© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
electroCore, Inc. (ECOR) stock declined over -3.55%, trading at $4.49 on NASDAQ, down from the previous close of $4.65. The stock opened at $4.66, fluctuating between $4.42 and $4.75 in the recent session.
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
| Employees | 73 |
| Beta | 0.34 |
| Sales or Revenue | $16.03M |
| 5Y Sales Change% | 4.71% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |